Active Biotech

New reports from Active Biotech detailed

Published in Physician Law Weekly, February 14th, 2007

New reports from Active Biotech detailed.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Active Biotech.

Report 1: Active Biotech (ACTI.ST) announced the successful completion of three clinical phase I studies of Anyara for the treatment of advanced non-small cell lung cancer (NSCLC), renal cell cancer (RCC) and pancreatic cancer (PC).

These studies confirm that Anyara has now demonstrated pharmacological proof of concept.

"These important results mean that the Anyara concept of tumor treatment has been fully validated also in man. In addition, the results...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2007-02-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry